Cussenot O - Search Results

1

[Mutation of the FGFR3 oncogene is an independent and favorable prognostic factor for tumor-specific survival in patients with urothelial carcinoma of the upper urinary tract].

Burger M, Catto J, van Oers J, Zwarthoff E, Hamdy FC, Meuth M, Azzouri AR, Cussenot O, Wild PJ, Stoehr R, Hartmann A. Burger M, et al. Among authors: cussenot o. Verh Dtsch Ges Pathol. 2006;90:244-52. Verh Dtsch Ges Pathol. 2006. PMID: 17867603 German.

2

Behavior of urothelial carcinoma with respect to anatomical location.

Catto JW, Yates DR, Rehman I, Azzouzi AR, Patterson J, Sibony M, Cussenot O, Hamdy FC. Catto JW, et al. Among authors: cussenot o. J Urol. 2007 May;177(5):1715-20. doi: 10.1016/j.juro.2007.01.030. J Urol. 2007. PMID: 17437794

3

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.

Roupret M, Catto J, Coulet F, Azzouzi AR, Amira N, Karmouni T, Fromont G, Sibony M, Vallancien G, Gattegno B, Meuth M, Hamdy FC, Cussenot O. Roupret M, et al. Among authors: cussenot o. J Med Genet. 2004 Jul;41(7):e91. doi: 10.1136/jmg.2003.017871. J Med Genet. 2004. PMID: 15235034 Free PMC article. No abstract available.

4

S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors.

Rehman I, Cross SS, Azzouzi AR, Catto JW, Deloulme JC, Larre S, Champigneuille J, Fromont G, Cussenot O, Hamdy FC. Rehman I, et al. Among authors: cussenot o. Br J Cancer. 2004 Aug 16;91(4):739-44. doi: 10.1038/sj.bjc.6602034. Br J Cancer. 2004. PMID: 15280928 Free PMC article.

5

[Carcinogenic pathways and natural history of upper tract urothelial carcinomas: state-of-the-art review for the yearly scientific report of the French National Association of Urology].

Seisen T, Cancel-Tassin G, Colin P, Cussenot O, Rouprêt M. Seisen T, et al. Among authors: cussenot o. Prog Urol. 2014 Nov;24(15):943-53. doi: 10.1016/j.purol.2014.06.010. Epub 2014 Jul 30. Prog Urol. 2014. PMID: 25158326 Review. French.

6

Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract.

Compérat E, Roupret M, Chartier-Kastler E, Bitker MO, Richard F, Camparo P, Capron F, Cussenot O. Compérat E, et al. Among authors: cussenot o. J Urol. 2008 Mar;179(3):868-72; discussion 872. doi: 10.1016/j.juro.2007.10.079. Epub 2008 Jan 25. J Urol. 2008. PMID: 18221954

7

[Genetic aspects in cancers of the prostate].

Cussenot O, Valeri A, Meria P, Berthon P, Fournier G, Teillac P, Mangin, Le Duc A. Cussenot O, et al. Pathol Biol (Paris). 1996 Oct;44(8):737-43. Pathol Biol (Paris). 1996. PMID: 8977935 Review. French.

8

[Natural history and prognostic factors of prostate cancer].

Cussenot O. Cussenot O. Rev Prat. 1994 Mar 1;44(5):580-5. Rev Prat. 1994. PMID: 8066393 French.

9

[Prognostic value of PD-1/PD-L1 expression in upper tract urothelial carcinoma].

Campedel L, Seisen T, Cussenot O, Comperat E, Varinot J, Rouprêt M, Cancel-Tassin G. Campedel L, et al. Among authors: cussenot o. Prog Urol. 2018 Dec;28(16):900-905. doi: 10.1016/j.purol.2018.08.009. Epub 2018 Sep 13. Prog Urol. 2018. PMID: 30219646 Review. French.

10

[Primary upper urinary tract tumors and subsequent location in the bladder].

Azémar MD, Audouin M, Revaux A, Misraï V, Comperat E, Bitker MO, Chartier-Kastler E, Richard F, Cussenot O, Rouprêt M. Azémar MD, et al. Among authors: cussenot o. Prog Urol. 2009 Oct;19(9):583-8. doi: 10.1016/j.purol.2009.03.007. Epub 2009 May 9. Prog Urol. 2009. PMID: 19800544 Review. French.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters